Cubist Systematic Strategies’s Arcutis Biotherapeutics ARQT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-128,248
| Closed | -$1.79M | – | 1459 |
|
|
2024
Q4 | $1.79M | Buy |
+128,248
| New | +$1.79M | 0.01% | 632 |
|
|
2024
Q2 | – | Sell |
-20,705
| Closed | -$205K | – | 1477 |
|
|
2024
Q1 | $205K | Sell |
20,705
-86,463
| -81% | -$857K | ﹤0.01% | 1663 |
|
|
2023
Q4 | $346K | Buy |
+107,168
| New | +$346K | ﹤0.01% | 1469 |
|
|
2023
Q1 | – | Sell |
-84,022
| Closed | -$1.24M | – | 2824 |
|
|
2022
Q4 | $1.24M | Buy |
84,022
+83,033
| +8,396% | +$1.23M | 0.01% | 1603 |
|
|
2022
Q3 | $19K | Sell |
989
-48,058
| -98% | -$923K | ﹤0.01% | 3440 |
|
|
2022
Q2 | $1.05M | Buy |
49,047
+42,478
| +647% | +$905K | 0.01% | 2090 |
|
|
2022
Q1 | $127K | Sell |
6,569
-7,216
| -52% | -$140K | ﹤0.01% | 3153 |
|
|
2021
Q4 | $286K | Buy |
13,785
+12,466
| +945% | +$259K | ﹤0.01% | 2827 |
|
|
2021
Q3 | $32K | Sell |
1,319
-1,303
| -50% | -$31.6K | ﹤0.01% | 2865 |
|
|
2021
Q2 | $72K | Sell |
2,622
-11,147
| -81% | -$306K | ﹤0.01% | 2754 |
|
|
2021
Q1 | $398K | Buy |
13,769
+12,061
| +706% | +$349K | 0.01% | 2085 |
|
|
2020
Q4 | $48K | Buy |
1,708
+301
| +21% | +$8.46K | ﹤0.01% | 2468 |
|
|
2020
Q3 | $41K | Buy |
+1,407
| New | +$41K | ﹤0.01% | 2378 |
|